Mushrooms are used for a variety of biotechnological applications, particularly for the production of food, enzymes, dietary supplements, pharmaceutical compounds, feed supplements. Basidiomycetes mushroom fungi have been known for their nutritional values they can be considered as functional foods which can provide health benefits beyond the traditional nutrients. Mushroom represents a major and untapped source of potent new pharmaceutical products. A wide range of activities including antitumour, cardiovascular and antimicrobial are reported in mushrooms. In developing countries like India mushroom progress is a boon in the field of food, medicine, and in generating employment. The alternative systems of medicine utilize the curative properties of mushrooms. They are also known to possess promising antioxidative, cardiovascular, hypercholesterolemia, antimicrobial, hepato-protective and anticancer effects. The present study aimed to evaluate antimicrobial and antihaemolytic activities of various extracts of Basidiomycetes mushroom fungi. Different Basidiomycetes mushroom fungi extracts (Hot water, Acetone and Hexane) were tested for antimicrobial and antihaemolytic activities. Among these different extracts of Basidiomycetes mushroom fungi the hexane extract of Pleurotus pulmonarius showed potential antimicrobial and antihaemolytic activity. The results of this study suggest the possibility of using Basidiomycetes mushroom fungi as natural sources for the pharmaceutical industry and could act as safe and cost-effective with potential biological activities. These findings encourage studying these fungal strains further for their potential biological applications.
INTRODUCTION
Mushrooms have become attractive as a functional food and as a source for the development of drugs and nutraceuticals responsible with their antioxidant, antitumorand antimicrobial properties 1, 2 . Besides their pharmacological features, mushrooms are becoming more important in our diet due to their nutritional value, related to high protein and low fat / energy contents 3 . Trametes versicolor (L.) Lioyd has been considered among the 25 major medicinal macrofungi worldwide 4 , mainly due to its traditional usage. In recent years Basidiomycetes and other higher fungi including some recognized medicinal mushrooms have been recognized medicinal mushrooms have been re-investigated as sources of novel antibiotics mainly as a result of increasing difficulty and the cost of isolating novel bioactive compounds from the Actinomycetes and Streptomycetes 5 .
A variety of mushrooms have been used traditionally for the maintenance of health and for prevention and treatment of diseases such as cancer, inflammation, viral diseases, hypercholesterolemia, blood platelet aggregation and hypertension [6] [7] [8] [9] [10] . Medical mycology is as old as traditional uses of mushrooms. They have been used in medicine since the Neolithic and Paleolithic eras 11 .
The present research possesses an idea about the antibiotic activity of some of the important edible Basidiomycetes mushroom fungi. Several edible mushrooms have traditionally been used in China and other countries like Japan, Korea, USA etc. An old Chinese proverb regarding mushrooms states that "medicine and food have a common origin". [12] [13] [14] . The medicinal beneficial effects of Pleurotus species were discovered independently in different countries. Oyster mushrooms (Pleurotus species) are excellently edible and nutritious, rank among one of the most widely cultivated mushrooms in the world 15 .
The screening of mushrooms from different ecological and geographical regions of India is still required to identify, isolate, design, develop, modify or to prepare new pharmacologically active compounds from wild mushrooms. Considering the immense importance of mushrooms as a source of food as well as herbal medicines, the present study is dealt with a recent insight on the pharmaceutical potential of some edible Basidiomycetes mushroom fungi.
MATERIALS AND METHODS

Basidiomycetes Fungi
The pure cultures of basidiomycetes mushroom fungal strains used in the present study were 
Storage and maintenance of Basidiomycetes fungi
Pure cultures of fungi were stored at 10°C. Sub-culturing was performed every month to ensure that the organisms remained viable. The mycelial agar plugs (7 mm) from the stock cultures were aseptically transferred to fresh Potato Dextrose Agar medium and then incubated at room temperature (28 ± 2ºC) until confluent growth was achieved.
Test organisms
The bacterial strains used throughout this study as test organisms for investigating the anti-microbial activity of the selected mushroom fungi were Bacillus sp., Proteus sp., and Staphylococcus aureus. All the bacterial strains were grown in nutrient broth aerobically in Erlenmeyer flasks and were stored as nutrient agar slants at 4°C.
Anti-microbial activity
Screening for antimicrobial activity against microorganisms including bacteria such as Bacillus sp., Proteus sp. and Staphylococcus aureus was carried out to determine whether the mushroom extracts possessed any biological activity. Antimicrobial activity was measured by agar well diffusion assay. Fresh cultures of test bacterial strains were grown overnight in nutrient broth to get 10 5 CFU/ml. 0.1ml of each bacterial suspension was used to inoculate individual petridish containing nutrient agar medium with a sterile non-toxic cotton swab on a wooden applicator. Eight millimeter diameter 5 wells were punched in the agar plates. Aliquots (25 µl, 50 µl, 75 µl, 100 µl and 125 µl) of the various mycelial extracts were used to fill the wells. The plates were incubated at 28 ± 2°C overnight. Anti-bacterial activity was recorded by measuring the zone of growth inhibition around the well.
Anti-haemolytic activity
By centrifugation the erythrocytes from cow blood were separated and washed with phosphate buffer (pH 7.4). With phosphate buffered saline the erythrocytes were then diluted to give 4% suspension. To 2ml of the erythrocyte suspension 500μg of extract/ml of saline buffer were added and with saline buffer the volume was made up to 5ml. At room temperature the mixture was incubated for 5 min and in saline buffer 0.5ml of H2O2 solution was added to induce the oxidative degradation of the membrane lipids. The concentration of H2O2 in the reaction mixture was adjusted to bring about 90% haemolysis of blood cells after 240 min. After incubation the reaction mixture was centrifuged at 1500 rpm for 10 min and the extend of haemolysis was determined by measuring the absorbance at 540nm corresponding to haemoglobin liberation. The percentage of haemolysis was calculated by using the formula [(A0-A1)/A0)] X100, where A0 is the absorbance of the control (reaction mixture without extract) and A1 is the absorbance of the extract/ standard.
RESULT AND DISCUSSION
Screening for antibacterial activity against microorganisms including bacteria such as Bacillus sp., Proteus sp. and Staphylococcus aureus was carried out to determine whether the extracts of Basidiomycetes mushroom fungi shows any biological activity. The result of the evaluation revealed that hexane extract of Pleurotus pulmonarius showed the significant activity, acetone extract of Schizophyllum commune showed the moderate activity and hexane extract of Pleurotus eryngii showed the least activity. Lipid oxidation of cow blood erythrocytes membrane mediated by hydrogen peroxide induces membrane damage and subsequent haemolysis. The result of the evaluation revealed that hexane extract of Pleurotus pulmonarius has high significant efficiency in inhibiting radical induced red blood cell haemolysis with 97.39%. 
CONCLUSION
The significant pharmacological effects and physiological properties of mushrooms are bio regulation (immune enhancement), maintenance of homeostasis and regulation of biorhythm, cure of various diseases and prevention and improvement from life threatening diseases such as cancer, cerebral stroke and heart diseases. Haemolyses has a long history of use in measuring free radical damage and its inhibition by antioxidants but only few studies have been performed with erythrocytes in whole blood. In this study, use of biological test based on free radical induced erythrocytes lysis in cow blood was performed. Lipid oxidation of cow blood erythrocytes membrane mediated by H2O2 induced membrane damage and subsequently haemolysis. A high significant efficiency in inhibiting radical induced red blood cell haemolyses was observed for that the hexane extract of Pleurotus pulmonarius. Edible Basidiomycetes mushroom fungi which taken for our investigation were act as a non-antibiotic alternative for preventing many bacterial diseases. Meanwhile all the extracts showed effective antimicrobial activities among which the hexane extract of Pleurotus pulmonarius showed high significant antimicrobial activity. Using these edible Basidiomycetes mushroom fungi leads to reducing amount of antibiotics prescribed for treatment of bacterial diseases and preventing drug resistance. This study demonstrated that the extracts of edible Basidiomycetes mushroom fungi act as a modern medicine for bacterial diseases. The advanced pharmacological screening of these edible plants using the modern tool may leads to some new drug.
